首页 | 本学科首页   官方微博 | 高级检索  
检索        

三七总皂苷调控巨噬细胞对乳腺癌细胞MDA-MB-231侵袭迁移影响
引用本文:冯彬彬,毛勇坡,牛小花,杨策,张建海,李飞.三七总皂苷调控巨噬细胞对乳腺癌细胞MDA-MB-231侵袭迁移影响[J].中国医院药学杂志,2022,42(22):2325-2330.
作者姓名:冯彬彬  毛勇坡  牛小花  杨策  张建海  李飞
作者单位:1. 重庆三峡医药高等专科学校药学院, 重庆 404120;2. 重庆市抗肿瘤天然药物工程技术研究中心, 重庆 404120;3. 三峡库区道地药材开发利用重庆市重点实验室, 重庆 404120;4. 成都大学食品与生物工程学院, 四川 成都 610106;5. 陆军军医大学基础医学院生物医学分析测试中心, 重庆 400038
基金项目:重庆市卫健委中医药项目(编号:ZY201702138);校级自科项目(编号:2016xzz05);重庆市科技局自科基金项目(编号:CSTC2012jjA10012);重庆市教委自然基金项目(编号:KJQN201802709,KJQN202102714)
摘    要:目的:探讨三七总皂苷(Panax notoginseng saponins,PNS)通过调控巨噬细胞对乳腺癌细胞MDA-MB-231侵袭迁移的影响。方法:培养MDA-MB-231和Raw264.7细胞,给予不同浓度PNS,采用MTT与流式细胞术(Flow Cytometry,FCM)分别检测不同浓度PNS对MDA-MB-231与巨噬细胞Raw264.7增殖与凋亡的影响;划痕实验检测不同浓度PNS处理的Raw264.7细胞的条件培养基对乳腺癌细胞MDA-MB-231迁移的影响;Transwell实验检测不同浓度PNS与巨噬细胞共同作用对乳腺癌细胞MDA-MB-231侵袭的影响;ELISA与流式细胞术检测不同浓度PNS对巨噬细胞相关细胞因子分泌及蛋白表达的影响。结果:PNS可以剂量依赖性地抑制MDA-MB-231与Raw264.7细胞的增殖,高浓度PNS溶液可以显著增加细胞凋亡;低浓度(20,50μg·mL-1)PNS巨噬细胞条件培养基可以抑制MDA-MB-231的迁移;低浓度(20,50μg·mL-1)PNS与巨噬细胞共培养可以明显抑制MDA-MB-231的侵袭;低浓度(20,50μg·mL-1)PNS促进巨噬细胞IL-6与TNF-α的分泌,并上调巨噬细胞表面CD86的表达水平。结论:PNS可通过调控巨噬细胞抑制乳腺癌细胞MDA-MB-231侵袭、迁移,并可通过调控巨噬细胞向M1型巨噬细胞极化,进而发挥抑制肿瘤的作用。

关 键 词:三七总皂苷  乳腺癌细胞  巨噬细胞  
收稿时间:2022-04-24

Panax notoginseng saponins regulates macrophage invasion of MDA-MB-231 in breast cancer cells migration effects
FENG Bin-bin,MAO Yong-po,NIU Xiao-hua,YANG Ce,ZHANG Jian-hai,LI Fei.Panax notoginseng saponins regulates macrophage invasion of MDA-MB-231 in breast cancer cells migration effects[J].Chinese Journal of Hospital Pharmacy,2022,42(22):2325-2330.
Authors:FENG Bin-bin  MAO Yong-po  NIU Xiao-hua  YANG Ce  ZHANG Jian-hai  LI Fei
Institution:1. School of Pharmacy, Chongqing Three Gorges Medical College, Chongqing 404120, China;2. Chongqing Engineering Research Center of Antitumor Natural Drugs, Chongqing 404120, China;3. Chongqing Key Laboratory of Development and Utilization of Genuine Medicinal Materials in Three Gorges Reservoir Area, Chongqing 404120;4. School of Food and Biological Engineering, Chengdu University, Sichuan Chengdu 610106, China;5. Biomedical Analysis Center, Army Medical University, Chongqing 400038, China
Abstract:OBJECTIVE To investigate the effect of Panax notoginseng saponinson the invasive migration of breast cancer cells MDA-MB-231 by regulating macrophages.METHODS MDA-MB-231and Raw264.7cells were cultured and given different concentrations of PNS,and the effects of different concentr ations of Panax notoginseng saponins(PNS)on the proliferation and apoptosis of MDA-MB-23 and macrophages Raw264.7 were detected by MTT and flow cytometry(FCM),respectively;scratch assay was performed to detect the effects of different concentrations of PNS treated Raw264.7cells treated with different concentrations of PNS on the migration of MDA-MB-231 breast cancer cells;Transwell assay to detect the effect of different concentrations of PNS and macrophages on the invasion of MDA-MB-231breast cancer cells;ELISA and flow cytometry to detect the effect of different concentrations of PNS on macrophage-related cytokine.The effects of PNS on macrophage-related cytokine secretion and protein expression were examined by ELISA and flow cytometry.RESULTS PNS dose-dependently inhibited the proliferation of MDA-MB-231 and Raw264.7 cells,and high concentrations of PNS solution significantly increased apoptosis;low concentrations(20,50 μg·mL-1)of PNS macrophage conditioned medium inhibited the migration of MDA-MB-231.Low concentrations(20,50 μg·mL-1)of PNS co-cultured with macrophages significantly inhibited the invasion of MDA-MB-231;low concentrations(20,50 μg·mL-1)of PNS promoted the secretion of IL-6 and TNF-α in macrophages and up-regulated the expression level of CD86 on the surface of macrophages.CONCLUSION PNS can inhibit the invasion and migration of breast cancer cells MDA-MB-231 by regulating macrophages,and can exert tumor suppressive effects by regulating the polarization of macrophages to M1-type macrophages.
Keywords:PNS  breast cancer cells  macrophages  
点击此处可从《中国医院药学杂志》浏览原始摘要信息
点击此处可从《中国医院药学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号